Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
Portfolio Pulse from Benzinga Insights
Recent analysis of options activity for Regeneron Pharmaceuticals (NASDAQ:REGN) reveals a predominantly bearish sentiment among traders, with significant trades indicating a price range target of $960 to $1280. Despite this, analysts maintain positive ratings with price targets averaging $1195.6.
June 25, 2024 | 7:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Options activity for Regeneron Pharmaceuticals shows a bearish sentiment with significant trades targeting a price range of $960 to $1280. Despite this, analysts maintain positive ratings with an average price target of $1195.6.
The majority of options trades are bearish, indicating a negative short-term outlook. However, analysts' positive ratings and higher price targets suggest a potential rebound or long-term confidence in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100